|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06160 BEONE MEDICINES
Nominal 
210.000 +10.500 (+5.263%) | 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/06 USD(K$) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | |
| Turnover | 3,218,509 | 32.309% | 2,432,579 | 1,680,818 | 1,043,062 | 648,198 |
| Cost of Sales | (341,745) | 3.682% | (329,608) | (263,067) | (177,779) | -- |
| Gross Profit | 2,876,764 | 36.795% | 2,102,971 | 1,417,751 | 865,283 | -- |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/06 USD(K$) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 13,787 | 13.782% | 12,117 | (10,222) | (45,515) | (117,650) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 571,674 | 374.619% | 120,449 | (349,346) | (704,402) | (978,834) | |
| Taxation | (107,310) | 331.675% | (24,859) | (22,209) | (25,166) | (22,090) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 464,364 | 385.787% | 95,590 | (371,555) | (729,568) | (1,000,924) | |
| 2026/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2025/06 USD(K$) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | |
| Net Finance Costs / (Income) | 17,062 | -- | (9,345) | (38,145) | (40,584) | (32,520) |
| Depreciation & Amortisation | 81,659 | 19.353% | 68,418 | 50,330 | 42,346 | 32,061 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 32.000 | 357.143% | 7.000 | -27.000 | -54.000 | -75.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.627 | -- | 2.449 | 2.447 | 2.770 | 3.945 |
| Remarks: | Real time quote last updated: 07/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 464,364 |
| %Change | 385.787% |
| EPS / (LPS) | USD 0.320 |
| NBV Per Share ($) | USD 3.627 |